Cart
sales@molnova.com
(+)-Nortrachelogenin
CAS No. 61521-74-2
(+)-Nortrachelogenin( Wikstromol )
Catalog No. M29329 CAS No. 61521-74-2
(+)-Nortrachelogenin is a lignan isolated from Wikstroemia indica C.A. Meyer (Thymelaeaceae). (+)-Nortrachelogenin possesses antileukemic activity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 314 | In Stock |
|
| 5MG | 308 | In Stock |
|
| 10MG | 444 | In Stock |
|
| 25MG | 658 | In Stock |
|
| 50MG | 904 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name(+)-Nortrachelogenin
-
NoteResearch use only, not for human use.
-
Brief Description(+)-Nortrachelogenin is a lignan isolated from Wikstroemia indica C.A. Meyer (Thymelaeaceae). (+)-Nortrachelogenin possesses antileukemic activity.
-
Description(+)-Nortrachelogenin is a lignan isolated from Wikstroemia indica C.A. Meyer (Thymelaeaceae). (+)-Nortrachelogenin possesses antileukemic activity.(In Vitro):(+)-Nortrachelogenin is moderately active against HIV-1 in vitro. (+)-Nortrachelogenin induces morphological deformation of P. oryzae mycelia with the MMDC value of 31.3 microM. (In Vivo):(+)-Nortrachelogenin showed effects on the central nervous system producing depression in rabbits.
-
In VitroWikstromol induces apoptosis and suppresses migration of MDA-MB-231 cells via inhibiting PI3K/Akt pathway.
-
In Vivo——
-
SynonymsWikstromol
-
PathwayApoptosis
-
TargetApoptosis
-
RecptorApoptosis
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number61521-74-2
-
Formula Weight374.38
-
Molecular FormulaC20H22O7
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCOc1cc(C[C@@H]2COC(=O)[C@@]2(O)Cc2ccc(O)c(OC)c2)ccc1O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Epristeride
Epristeride (ONO-9302) is an orally active, selective and non-competitive steroidal 5-α-reductase isoform 2 inhibitor that inhibits SR isoform 2.
-
SACLAC
SACLAC is a cysteine asparaginase activation inhibitor with antitumor activity that decreases AML cell viability, inhibits AML cell proliferation, increases AML cell death, and induces apoptosis of AML cells, and is used in the study of acute myeloid leukemia and cancer.
-
TJ08
TJ08 is a 1,2,5-trisubstituted benzimidazole derivative with anticancer properties that effectively induces G1/S phase blockade while promoting apoptotic effects in a variety of cancer cells.
